1) extracorporeal membrane oxygenation
无泵驱动体外膜肺
1.
Changes of ET-1 and TNF-α in dog ARF model during bilateral femoral arteriovenous shunt for extracorporeal membrane oxygenation;
无泵驱动体外膜肺转流治疗急性呼吸衰竭犬过程中血浆和肺组织ET-1、TNF-α水平的变化
2) femoral arteriovenous extracorporeal membrane oxygenation
动脉-静脉无泵驱动体外膜肺氧合
3) bilateral femoral arteriovenous extracorporeal membrane oxygenation
双侧股动脉-股静脉无泵驱动体外膜肺
1.
AIM: To study the dynamic change of the endo- thelins-1 (ET-1) in plasma and lung tissue of dogs with acute respiratory failure (ARF) treated by bilateral femoral arteriovenous extracorporeal membrane oxygenation (bAV-ECMO).
目的观察双侧股动脉-股静脉无泵驱动体外膜肺(bAV-ECMO)治疗急性呼吸衰竭犬,血浆及肺组织内皮素-1(ET-1)的表达变化。
4) pumpless
无泵驱动
1.
To avoid the complications of tradional pumped,venous-arterial extracorporeal membrane oxygenation ECMO,a pumpless extracorporeal membrane oxygention(pECMO) was established.
对无泵驱动的动-静脉途径体外膜肺氧合支持疗法进行分析总结,并与需泵驱动的静-动脉体外膜肺氧合支持疗法进行对比,结果证明体外膜肺氧合支持疗法采取动-静脉途径比静-动脉体途径更有利。
5) Pumpless extracorporeal lung assist
无泵型体外肺辅助技术
6) extracorporeal membrane oxygenation
体外膜肺
1.
Objective To evaluate whether extracorporeal membrane oxygenation (ECMO) with high-volume hemofiltration (HVHF) improves hypoxemia and renal function in patients with multiple organ dysfunction syndrome (MODS).
目的 探讨高容量血液滤过(HVHF)联合体外膜肺(ECMO)对多器官功能障碍综合征(MODS)患者低氧血症和肾功能的影响。
补充资料：肺炎克氏杆菌(Klebsiella pneumoniae),菌体外有一层荚膜
[图]
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条